UnknownNot Applicable

Sensory Rehabilitation in Chemotherapy Induced Peripheral Neuropathy (CIPN)

Israel12 participantsStarted 2022-08-01

Plain-language summary

Physiotherapist research about Sensory rehabilitation in chemotherapy induced peripheral neuropathy (CIPN) with the aid of questioners and physiotherapy practice

Who can participate

Age range18 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Sensory damage / neuropathy that existed even before the start of chemotherapy
✕. Incidents of recurrent falls even before the start of chemotherapy (over 2 falls for 6 months)
✕. Central nervous system involvement
✕. Major pre-morbid orthopedic lower limb impairment
✕. Hebrew language not sufficient for assessment and treatment

What they're measuring

TNAS

Timeframe: 2 years

VAS

Timeframe: 2 years

FABS

Timeframe: 2 years

TUG

Timeframe: 2 years

NSA

Timeframe: 2 years

Semmes-Weinstein monofilament testing

Timeframe: 2 years

LEPT

Timeframe: 2 years

Allodynia

Timeframe: 2 years

Trial details

NCT IDNCT05382520

SponsorAssaf-Harofeh Medical Center

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2024-01-01

Contact for this trial

Hadas Ofek

972544666412 hadasbarkolofek@gmail.com

View on ClinicalTrials.gov More CIPN trials